Concord Acquisition Corp II (CNDAW)

Concord Acquisition Corp II warrants (ticker CNDAW) are a derivative security tied to the SPAC. They grant the holder the right, but not the obligation, to purchase one share of Concord common stock at a specified exercise price (typically around 11.50 dollars per share). Each warrant is a leveraged bet on whether the SPAC will complete a merger and whether the resulting merged company will perform well, because warrant value is concentrated in the upside potential.

When investors buy SPAC shares, many also receive warrants as part of the deal package. Some warrants are issued in separate public offerings. The warrant gives a fractional stake in the future without owning the underlying shares, similar to a call option but with different tax and structural treatment. Understanding warrants is essential to understanding the full return profile of a SPAC investment and the incentive structure that shapes SPAC sponsor behavior.

How SPAC warrants work

A warrant is a contract that says: the holder can purchase one share of Concord common stock at the exercise price (let’s say 11.50 dollars) at any point until a specified expiration date (often several years after the SPAC is formed). If Concord common stock trades at 15 dollars, a warrant is worth at least 3.50 dollars (15 minus 11.50), because an investor can buy the stock at 15 and immediately exercise the warrant to buy at 11.50, netting a 3.50 dollar profit. If Concord trades at 10 dollars, the warrant is worthless; no one will exercise a right to buy at 11.50 when they can buy in the market at 10.

Warrants are typically sold to SPAC investors alongside common shares as an incentive to participate. A typical SPAC might issue one warrant for every four shares purchased, giving the buyer leverage without requiring a larger upfront capital commitment. Some SPACs issue full warrants (one warrant per share); others issue partial warrants or a mix of different warrant classes with different exercise prices and terms.

The leverage is the point

The reason warrants exist is leverage. Suppose you invest 1,000 dollars in Concord SPAC shares at 10 dollars each, buying 100 shares. You also receive 25 warrants. If Concord merges with a company that becomes worth 20 dollars per share, your 100 shares are now worth 2,000 dollars — a 100 percent gain, or 1,000 dollars profit. Your 25 warrants, with an 11.50 dollar exercise price, are now worth at least 250 dollars each (the 8.50 dollar difference between 20 and 11.50), or 6,250 dollars total. Your total position went from 1,000 dollars to 8,250 dollars — more than an 8x return — because the warrants captured the upside with only a fractional capital outlay.

This leverage works both ways. If Concord common stock falls to 5 dollars after the merger, your 100 shares are worth 500 dollars, a 50 percent loss. Your warrants become worthless because exercising them to buy at 11.50 makes no sense if you can buy at 5 dollars on the open market. So you lost 100 percent on the warrant position while losing 50 percent on the shares. The leverage amplifies both gains and losses.

Warrant pricing and volatility

Before a SPAC completes a merger, warrant pricing is driven primarily by the probability of merger completion and the timing. A SPAC with a strong sponsor and clear merger criteria might see warrants trade at a high price because investors believe a deal will happen. A SPAC struggling to find a target might see warrants decay as the deadline approaches, because the expiration value if the merger does not complete is often zero (the warrant simply expires).

After a merger closes, warrant pricing becomes more complex. The warrant is now a call option on a real company, and its price depends on the company’s stock volatility, the time value remaining, and how far in-the-money or out-of-the-money the warrant is. High volatility increases warrant value; companies approaching the warrant expiration date with stock below the exercise price see warrants decay toward zero.

The moral hazard in warrant structures

Warrant structures create an interesting incentive problem. SPAC sponsors, who retain a large stake through the sponsor promote, benefit when the merged company’s stock rises. But warrant holders also benefit from stock appreciation and have an outsized claim on that upside due to leverage. This can align incentives — both sponsors and warrant holders want the merged company to succeed — or it can misalign them.

If a SPAC merger looks like it will disappoint and the stock is falling, warrant holders are hurt more than shareholders because their position is more levered. They may push for a deal liquidation and redemption early, cutting their losses, while sponsors may push to gamble on a merger in hopes of a rebound. Warrant holders also have less direct control than shareholders — they do not typically have voting rights in SPAC proxy contests.

There are also redemption mechanics that affect warrant holders. When some SPAC shareholders redeem their shares after a merger announcement, the trust account is depleted, which can affect the merged company’s capital structure. Warrant holders, who did not redeem, sometimes see their position diluted or see the merged company take on additional leverage to cover the lost capital.

Expiration and call provisions

Most SPAC warrants have an expiration date of five to ten years from issuance, giving holders a long window to wait for a merger or exercise the warrant. However, some SPAC agreements include a call provision that lets the company redeem the warrants early if the stock trades above a certain price (often 18 to 20 dollars) for a set number of consecutive days. If the call is exercised, warrant holders must either exercise at the strike price (purchasing shares) or lose their warrants and receive a small redemption payment.

The call provision is often controversial because it reduces warrant holders’ upside optionality. If a company’s stock soars to 30 dollars and the call is triggered at 20 dollars, warrant holders are forced to exercise at 11.50 and immediately own shares at 20 dollars instead of participating in the full upside. Sophisticated investors scrutinize call provisions carefully before buying SPAC warrants.

Warrant holders versus shareholder

Warrant holders have less protection and less control than equity shareholders. They do not vote on mergers or company matters. They have no claim on dividends (if any are paid). They have no claim on assets in bankruptcy above what the exercise price buys them. If a merger fails and the SPAC liquidates, warrant holders are typically last in line for the remaining trust account capital and often receive nothing.

The trade-off is leverage and upside participation. A warrant holder who buys Concord warrants at 50 cents, exercises at 11.50, and the merged company’s stock rises to 50 dollars has captured enormous returns. But the same warrant holder who watches the stock fall to 5 dollars has lost the entire 50-cent investment, while shareholders at least still own an asset worth 5 dollars per share.

Tax and structural considerations

Warrant exercise triggers tax consequences. When you exercise a warrant, you buy shares at the strike price, which is a taxable purchase; any subsequent gain is then subject to capital gains tax. Warrant holders must be aware of exercise timing and tax planning. The warrant itself is also subject to different tax treatment than equity, which can affect how they fit into a portfolio or tax-loss-harvesting strategy.

How to research SPAC warrants

Review the warrant agreement filed with the SPAC’s SEC registration statement to understand the exercise price, expiration date, and any call provisions. Look at the sponsor’s track record with prior SPACs — do they complete mergers, and do those merged companies perform well or poorly? The sponsor’s incentives are aligned with warrant holders in some ways (wanting the stock to rise) but misaligned in others (the sponsor has a large promote stake and might accept a mediocre merger to close early).

Check the merger agreement if one is announced, looking for any repricing of warrants, dilution, or changes to their terms. Some SPAC sponsors have used warrant repricing or cancellation as a way to recover value for the combined company at warrant holders’ expense — a sign of conflicts of interest.

Finally, do not mistake warrant leverage for alpha. Warrants give you leverage, which can amplify returns in good outcomes and losses in bad ones. The fundamental question remains: is the SPAC sponsor competent, and does the merged company have a real business? Warrants just change the leverage on that bet.